A Dose-Finding, Efficacy and Safety Study of YY-351 in Patients With Type 2 Diabetes

NCT01008163 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: YY-351/Placebo
DRUG: YY-351/Placebo
DRUG: YY-351
DRUG: Placebo

Sponsor

Yuyu Pharma, Inc.